Many clinicians are blissful to prescribe compounded GLP-1 weight reduction medicine, however some consultants warning that the restricted oversight could expose sufferers to pointless dangers. Juliana Simonetti, MD, a codirector of the great weight administration program on the College of Utah in Salt Lake Metropolis, says anybody shopping for compounded medicine from a doubtful supply runs the chance of utilizing medicines that pose security dangers.
“I am very clear in telling my sufferers to not get compounded variations,” she says. “I really feel their ache and desperation, however I am telling them to not do it as a result of these are harmful practices.”
Different consultants agree with that opinion. Andrew Kraftson, MD, the director of the load navigation program at Michigan Drugs in Ann Arbor, believes strongly within the worth of medicines like semaglutide and understands why individuals are scrambling to get the medicine. He factors out that weight problems is extremely stigmatized and undertreated.
“There’s this sense of urgency that is driving folks to make rash choices,” he says. “They really feel like, ‘That is on the market now. I ought to have been on it yesterday.’”
However with out FDA oversight, Dr. Kraftson says, compounded variations are too dangerous. “It is problematic that there’s this inherent battle of curiosity,” he says about suppliers who may be keen to compromise security in pursuit of revenue.
